← Back to Blog

Patient Guides

Florida Medical Marijuana Qualifying Conditions: A Plain-English 2025 Guide

12 min read · 2,580 words

A doctor's wooden desk with stethoscope, blank clipboard, and a single dried cannabis leaf beneath afternoon louvered-blind light.
CD
Reviewed by

FloridaMJ Compliance Desk

The FloridaMJ Compliance Desk reviews every published page for accuracy against the Florida Statutes (Chapter 381.986), the Florida Administrative Code (64ER22-x), and current Office of Medical Marijuana Use (OMMU) guidance before publication.

Last reviewed

Qualifying for a Florida medical marijuana card is narrower than most prospective patients think and broader than most popular guides admit. The statute lists ten enumerated conditions and a discretionary "comparable" clause that gives qualified physicians meaningful — but not unlimited — clinical room. This guide walks through each statutory qualifying condition, what evidence the OMMU expects, the realistic clinical conversation, and the honest gray zones where applicants fail certification more often than they pass.

The Statutory List, Verbatim

§ 381.986(2), F.S. lists the following qualifying medical conditions for a Florida medical marijuana certification[1]:

  1. Cancer
  2. Epilepsy
  3. Glaucoma
  4. Positive status for human immunodeficiency virus (HIV)
  5. Acquired immune deficiency syndrome (AIDS)
  6. Post-traumatic stress disorder (PTSD)
  7. Amyotrophic lateral sclerosis (ALS)
  8. Crohn's disease
  9. Parkinson's disease
  10. Multiple sclerosis (MS)
  11. A medical condition of the same kind or class as, or comparable to, those enumerated above
  12. A terminal condition diagnosed by a physician other than the qualified physician
  13. Chronic nonmalignant pain

The "chronic nonmalignant pain" addition was a 2017 statutory amendment and is the single most-used qualifying pathway in Florida — not because of laxity, but because chronic pain is genuinely common and well-documented in Florida's older patient population. The OMMU also maintains plain-English patient guidance through its Know The Facts MMJ portal[2].

What Each Condition Requires in Practice

Cancer

Active oncologic diagnosis. Pathology report or oncologist letter is the standard documentation. Patients in remission with active surveillance and ongoing treatment-related symptoms (chemotherapy-induced nausea, neuropathy, anorexia, sleep disturbance) generally qualify. Patients with a fully-resolved historical cancer and no active symptoms are usually certified under "comparable" or chronic pain rather than cancer itself.

Epilepsy

Neurologist diagnosis with seizure history documentation. EEG records, MRI imaging, and current AED (anti-epileptic drug) regimen documentation accelerate the certification. Pediatric patients require a separate pediatric-qualified certifying physician under § 381.986(4)(b), F.S.

Glaucoma

Ophthalmologist diagnosis with intraocular pressure history. Glaucoma is a historical qualifying condition retained from the original Compassionate Use Act, though contemporary ophthalmology rarely treats cannabis as first- or second-line glaucoma therapy because of duration-of-effect limits.

HIV / AIDS

Positive HIV status documentation from the treating infectious disease physician. HIV-related symptoms — wasting, neuropathy, antiretroviral-induced nausea, sleep disturbance — are the typical clinical justifications.

Post-Traumatic Stress Disorder (PTSD)

DSM-5 PTSD diagnosis from a Florida-licensed mental health professional or physician. Veterans with VA documentation are routinely certified; non-veteran PTSD patients should bring a current diagnostic evaluation, treatment history, and any psychotherapy or psychopharmacology records. PTSD is the most clinically documented anxiety-spectrum qualifying condition in the statute.

ALS, Parkinson's Disease, Multiple Sclerosis

Neurologist diagnosis. These three neurodegenerative conditions are explicit and uncontested. Cannabis is often used adjunctively for spasticity (MS), tremor (Parkinson's), and pain or sialorrhea (ALS).

Crohn's Disease

Gastroenterologist diagnosis with colonoscopy or imaging documentation. Ulcerative colitis is generally certified under the "comparable" clause rather than as a named condition.

Chronic Nonmalignant Pain

The statute defines chronic nonmalignant pain as pain caused by a qualifying medical condition or that originates from a qualifying medical condition and persists beyond the usual course of that condition. In practice, certifying physicians require:

  • Documented underlying diagnosis (degenerative disc disease, spinal stenosis, peripheral neuropathy, fibromyalgia, post-surgical pain syndrome, complex regional pain syndrome, etc.)
  • Pain history of at least six months, with treatment attempts
  • Imaging or specialist consultation when the underlying diagnosis warrants it
  • A current pain assessment and functional impact statement

The chronic pain pathway is real but is not a rubber stamp. Certifying physicians who certify pain without documentation are subject to disciplinary action by the Department of Health, and several have been sanctioned in the program's history.

"Comparable" Conditions

The "of the same kind or class as, or comparable to" clause is where most clinical discretion lives. Conditions routinely certified under this clause include:

  • Anxiety disorders (generalized anxiety, panic disorder, social anxiety) — typically certified by mental-health-trained physicians with documented diagnosis and treatment history
  • Insomnia — typically certified when secondary to a documented qualifying condition or chronic pain
  • Migraine and chronic headache disorders
  • Inflammatory bowel disease beyond Crohn's (ulcerative colitis, microscopic colitis)
  • Autism spectrum disorder with severe behavioral symptoms
  • Severe nausea (cyclic vomiting syndrome, gastroparesis)
  • Tourette syndrome
  • Severe arthritis (rheumatoid, psoriatic) when chronic pain documentation is incomplete

The "comparable" clause is not a back door — the certifying physician must document the clinical reasoning that ties the condition to the statutory list, and that reasoning is auditable by the Department of Health.

The Pediatric Pathway

Patients under 18 may qualify but require a second opinion from a separate certifying qualified physician. The most common pediatric qualifying conditions are intractable epilepsy (Dravet syndrome, Lennox-Gastaut syndrome), severe autism with self-injurious behavior, and pediatric oncology. Pediatric certifications almost never authorize smokable flower; the typical formulary is high-CBD oral preparations and sublingual tinctures.

The Terminal Condition Pathway

A patient with a terminal condition diagnosed by a physician other than the certifying qualified physician — for example, a hospice or palliative-care diagnosis — qualifies under a separate statutory pathway. This pathway has the lowest documentation barrier in the program and the broadest formulary, including smokable flower.

Where Applicants Most Often Fail Certification

The OMMU does not publish denial statistics, but the recurring failure modes in patient certifications are consistent and avoidable:

  1. No documented diagnosis. "I have anxiety" is not a diagnosis. A current clinical evaluation from a Florida-licensed provider is.
  2. No treatment history. Florida physicians want to see what has been tried. A patient who has never seen a primary care provider and has no medication history is a harder certification than one with documented prior trials of conventional therapy.
  3. Out-of-state records that have not been transferred. A Florida physician will not certify based on records they cannot independently verify. Bring the records, or sign releases at the visit.
  4. Mismatched ID and registry name. The OMMU registry uses your legal name exactly as it appears on your government ID. A nickname on the application is a rejection.
  5. Failure to complete annual recertification. Certifications expire every 70 days for ordering purposes and the registry card expires annually. Lapsed cards require re-certification, not just renewal.

Cost, Timeline, and the State Fee Structure

Three cost components, each separate:

  • Physician certification fee. $150–$300 for the initial visit; $75–$200 for follow-ups. This is the physician's professional fee and is not regulated by the state.
  • OMMU application fee. $75 for the initial registry card; $75 for annual renewal.
  • MMTC product cost. Variable. Plan on $50–$100 per dispensary visit for typical maintenance therapy.

Total time from initial physician consultation to physical card in hand is typically 2–4 weeks, with the OMMU portion taking 10–14 business days after the patient submits a complete application. Patients can purchase from MMTCs once their digital approval is granted in the OMMU portal, even before the physical card arrives by mail.

A Realistic Patient Posture

Florida's qualifying-conditions framework is real, and the OMMU enforces it. Patients who arrive with a documented diagnosis, treatment history, and a clear functional-impact statement get certified efficiently and stay in the program without friction. Patients who arrive looking for a rubber stamp encounter exactly the friction the statute was written to create. The program is not difficult — it is documented.

Qualifying conditions, fees, and OMMU procedures change. Verify current requirements through the OMMU[2] and the Department of Health before scheduling certification visits.

Frequently Asked Questions

MMJ CardQualifying ConditionsOMMUFlorida Statute 381.986